Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug1486 | FFP Wiki | 1.00 |
| drug1044 | ConvP Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D018376 | Cardiovascular Abnormalities NIH | 1.00 |
| D006330 | Heart Defects, Congenital NIH | 0.58 |
| D009205 | Myocarditis NIH | 0.33 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| HP:0001627 | Abnormal heart morphology HPO | 0.58 |
| HP:0012819 | Myocarditis HPO | 0.33 |
| HP:0001626 | Abnormality of the cardiovascular system HPO | 0.17 |
Navigate: Correlations HPO
There is one clinical trial.
The study will analyze the prevalence of cardiac involvement of health care workers from the University Hospital of Salamanca (HUSA) who have overcome SARS-CoV-2 infection. Participants will undergo a clinical evaluation, electrocardiogram (EKG), cardiac magnetic resonance (CMR) and blood analysis including NT-proBNP, troponin, cellular and humoral immunity and genetics.
Description: Prevalence of myocardial damage suggestive of myocarditis assessed by cardiac magnetic resonance
Measure: Myocarditis Time: up to 3 monthsDescription: Prevalence of pericarditis assessed by clinical criteria
Measure: Pericarditis Time: up to 3 monthsDescription: Prevalence of atrial fibrillation on EKG
Measure: Atrial fibrillation Time: up to 3 monthsDescription: Prevalence of ischemic heart disease assessed by cardiac magnetic resonance
Measure: Ischemic heart disease Time: up to 3 monthsDescription: Prevalence of dilatation of right heart chambers assessed by cardiac magnetic resonance
Measure: Dilatation of right heart chambers Time: up to 3 monthsDescription: Prevalence of valvular heart disease assessed by cardiac magnetic resonance
Measure: Valvular hear disease Time: up to 3 monthsDescription: Prevalence of prolonged QT interval on EKG
Measure: Rhythm disorders Time: up to 3 monthsAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports